Company intelligence / Profile preview
寿仙谷药业
- Ownership
- Private
- Employees
- ~1200
- Development stage
- Other
Overview
Zhejiang Shouxiangu Pharmaceutical is a leading Chinese enterprise focused on the research, development, cultivation, and production of high-end Traditional Chinese Medicine (TCM). The company is best known for its specialized work with medicinal fungi, specifically Ganoderma lucidum (Lingzhi) and Dendrobium officinale. Shouxiangu maintains a complete industrial chain, from organic breeding and cultivation to deep processing and clinical application. Its flagship products, such as sporoderm-broken Ganoderma lucidum spore powder, are widely used for immune support and as adjuvant therapy in oncology. The company is listed on the Shanghai Stock Exchange and is recognized for its rigorous quality standards in the herbal medicine sector. It operates several R&D centers dedicated to the modernization of TCM through advanced extraction and purification technologies.
- Therapeutic areas
- OncologyCardiovascularImmunologyOther
- Modalities
- Traditional Chinese MedicineHerbal extractSmall molecule
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on 寿仙谷药业.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 寿仙谷药业.